Vertex Pharmaceuticals Incorporated
H-1B & green card sponsor · Headquarters Boston, MA · Industry: Professional and IT services
Short answer
Yes, Vertex Pharmaceuticals Incorporated sponsors H-1B visas. It had 137 certified H-1B filings in FY2026 so far, with a median salary of $132,200.
H-1B filings · FY2026 so far
137
#254 of 50,637 sponsors
Median salary
$132,200
+5% vs all H-1B ($126,372)
Green cards (PERM) · FY2026 so far
17
certified labor certifications
Most common level
Level IV
49% of filings with a level
By fiscal year
H-1B filings
*FY2026 covers Oct 1, 2025 – Jun 30, 2026 (9 months).
By fiscal year
Green card (PERM) certifications
Certified PERM cases by decision year, FY2023 onward.
FY2026 so far · all roles · 137 filings
What Vertex Pharmaceuticals Incorporated pays H-1B workers
- 10th pct
- $92,471
- 25th pct
- $110,900
- Median
- $132,200
- 75th pct
- $153,000
- 90th pct
- $178,131
DOL wage level of filings
- Level I · entry · 3%
- Level II · qualified · 31%
- Level III · experienced · 17%
- Level IV · fully competent · 49%
Of 136 filings that state a level. Level matters in the wage-weighted H-1B lottery.
FY2026 so far
Top roles Vertex Pharmaceuticals Incorporated sponsors
| Job title | Filings | Median |
|---|---|---|
| Senior Biostatistician II | 5 | $132,200 |
| Business Engagement Technology Senior Principal Analyst | 4 | $161,288 |
| Process Development Engineering Senior Scientist | 3 | $128,814 |
| Cybersecurity Principal Engineer | 3 | $147,600 |
| Principal Biostatistician | 3 | $152,000 |
| Business Engagement Technology Principal Analyst | 3 | $178,131 |
| Computational Genomics Senior Research Scientist | 3 | $134,971 |
| Formulation Research Scientist | 3 | $106,870 |
FY2026 so far worksites
Where they work
| City | Filings | Median |
|---|---|---|
| Boston, MA | 119 | $131,893 |
| San Diego, CA | 3 | $122,400 |
| Apex, NC | 2 | $164,400 |
| Cumberland, RI | 1 | $140,093 |
| Mclean, VA | 1 | $184,000 |
| Medford, MA | 1 | $147,600 |
| Monrovia, MD | 1 | $142,834 |
| Natick, MA | 1 | $129,600 |
Worker positions on FY2026 so far filings
Who Vertex Pharmaceuticals Incorporated files for
Already on an H-1B elsewhere? 20% of positions are transfers from other employers, so Vertex Pharmaceuticals Incorporated does hire people mid-H-1B.
PERM labor certification
Green card sponsorship
| Fiscal year | Certified | Denied | Withdrawn | Median days to decision |
|---|---|---|---|---|
| FY2023 | 17 | 0 | 0 | 289 |
| FY2024 | 11 | 0 | 0 | 401 |
| FY2025 | 13 | 0 | 1 | 502 |
| FY2026 so far | 17 | 0 | 0 | 515 |
PERM is the first government step for most EB-2 and EB-3 green cards. Nationally, PERM decisions take a median of 398 days right now — see live PERM times.
Not H-1B dependent
H-1B workers are below DOL's dependency threshold.
No willful-violator flag
No DOL finding of willful wage violations on its filings.
Not debarred
Not on DOL's PERM / H-2A / H-2B debarment list.
Immigration law firms used
Berry Appleman and Leiden LLP
Compare with similar sponsors
Questions about Vertex Pharmaceuticals Incorporated H-1B sponsorship
Does Vertex Pharmaceuticals Incorporated sponsor H-1B visas?
Yes. Vertex Pharmaceuticals Incorporated had 137 certified H-1B labor condition applications in FY2026 so far, ranking #254 among all U.S. sponsors.
What is the H-1B salary at Vertex Pharmaceuticals Incorporated?
The median is $132,200; the middle half of filings fall between $110,900 and $153,000. The most-filed title, Senior Biostatistician II, has a median of $132,200.
Does Vertex Pharmaceuticals Incorporated sponsor green cards?
Vertex Pharmaceuticals Incorporated had 17 certified PERM labor certifications in FY2026 so far. PERM is the first government step for most employment-based green cards.
More sponsors in Massachusetts · All H-1B sponsors
Source: U.S. Department of Labor, Office of Foreign Labor Certification LCA and PERM disclosure data, decisions through Jun 30, 2026. Salaries are annualized base wages from the filing and exclude bonus and stock. A certified LCA is not an approved H-1B petition. Updated Oct 4, 2026.